Profusa Inc (PFSA)

$0.76 -0.07 (-8.44%)
Market Cap 1.13M
Revenue (ttm) 0.00
Net Income (ttm) -8.71M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -0.59
Volume 156,700
Avg Vol 482,314
Day's Range N/A - N/A
Shares Out 1.36M
Stochastic %K 29%
Beta 0.01
Analysts Strong Buy
Price Target N/A

Company Profile

Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor glucose levels in interstitial fluid. Profusa, Inc. is based in Berkeley, California.

Industry: Medical Devices
Sector: Healthcare
Phone: 925 997 6925
Website: profusa.com
Address:
626 Bancroft Way, Suite A, Berkeley, United States
Eric1072
Eric1072 Mar. 19 at 5:25 AM
$PFSA Someone bought 16,325 shares at the close yesterday at 16 pm.
1 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 19 at 2:57 AM
$PFSA Ben Hwang is one corrupt SOB. HE WILL ROB YOU BLIND.
0 · Reply
Old_Bag
Old_Bag Mar. 19 at 1:04 AM
$PFSA worthless trash
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 19 at 12:47 AM
$PFSA You have no idea how the markets work. Are you even in age to trade? You Clown.
0 · Reply
alby777
alby777 Mar. 19 at 12:10 AM
$PFSA M&A? Glad to see Insiders owning a ton of PFSA shares!
0 · Reply
alby777
alby777 Mar. 18 at 11:37 PM
$PFSA Yes, insiders hold a significant portion of Profusa, Inc. (PFSA) shares. Key details regarding insider ownership (based on data available as of early 2026) include: Ownership Percentage: Insiders hold approximately 7.8% to 11% of Profusa's outstanding common stock. Individual Holdings: Key insiders hold large positions. For example, reports show individuals like Fred S. Knechtel and Jack E. Stover holding millions of shares. Insider Trading: Recent data suggests high insider activity, with reports of over 8 million shares bought in recent transactions. Significant Owners: Insiders, defined as executives, directors, and beneficial holders of more than 10%, play a major role in the company's equity ownership I'll buy more shares in this price range :)
1 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:52 PM
$PFSA this reminds me of nkgn They have great ideas, science but some how i tnink greed ends it
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:50 PM
$PFSA there is better next time
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:50 PM
$PFSA does Whang have oxygen is head? Perhaps
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 6:50 PM
$PFSA
0 · Reply
Latest News on PFSA
Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Feb 27, 2026, 9:15 AM EST - 19 days ago

Profusa To Withdraw S-1 Registration Statement to Pursue a Smaller, More Focused Offering

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Feb 19, 2026, 8:30 AM EST - 27 days ago

Profusa Receives Purchase Orders for Lumee™ Tissue Oxygen Monitoring and Raises 2026 Revenue Guidance

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Feb 13, 2026, 8:30 AM EST - 4 weeks ago

Profusa and Mayo Clinic collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies

Profusa Announces 1-for-75 Reverse Stock Split

Feb 5, 2026, 8:00 AM EST - 5 weeks ago

Profusa Announces 1-for-75 Reverse Stock Split

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Jan 29, 2026, 8:00 AM EST - 6 weeks ago

Profusa Presents Positive US-Study Clinical Results at Leipzig Interventional Course (LINC) 2026

Profusa Stock Spikes As Lumee System Targets Research Market

Jan 16, 2026, 12:51 PM EST - 2 months ago

Profusa Stock Spikes As Lumee System Targets Research Market

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Jan 16, 2026, 7:30 AM EST - 2 months ago

Profusa Launches Lumee™ Tissue Oxygen Healthcare Research Offerings, Initiating First Commercial Revenue

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Jan 8, 2026, 7:30 AM EST - 2 months ago

Profusa Adds Leading Greek Vascular Surgeon to Customer Base

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Dec 31, 2025, 7:30 AM EST - 2 months ago

Profusa Bolsters European Commercial Network with New French Distributor, MedSell

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Dec 30, 2025, 4:22 PM EST - 2 months ago

Profusa Stock Soars—To 12 Cents—On Debt Restructuring

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Dec 30, 2025, 7:30 AM EST - 2 months ago

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Dec 15, 2025, 7:30 AM EST - 3 months ago

Profusa U.S. Study Met Primary End Points as Presented at Late Breaking Clinical Trials at Paris Vascular Insights 2025

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Dec 11, 2025, 8:30 AM EST - 3 months ago

Profusa to Present US-Study Clinical Data at Leipzig Interventional Course (LINC) 2026

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Nov 24, 2025, 8:15 AM EST - 4 months ago

Profusa to Present Late Breaking U.S.-Based Clinical Trial Update at Paris Vascular Insights 2025

Profusa Announces Third Quarter Business and Financial Highlights

Nov 19, 2025, 5:44 PM EST - 4 months ago

Profusa Announces Third Quarter Business and Financial Highlights

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Oct 30, 2025, 7:30 AM EDT - 4 months ago

Profusa Outlines Potential Path to $250 Million Revenue by 2030, Driven by Sequential Lumee™ Oxygen and Glucose Monitoring Launches

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Oct 28, 2025, 8:30 AM EDT - 5 months ago

Profusa Completes Manufacturing Build-Out, On Track to Begin Product Shipments and Revenue in Early 2026

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Oct 22, 2025, 8:30 AM EDT - 5 months ago

Profusa Expands Sales Footprint with New Distributor for Lumee™ Oxygen Platform in Europe

Profusa Invests Additional $1 Million in Digital Treasury Assets

Oct 7, 2025, 8:15 AM EDT - 5 months ago

Profusa Invests Additional $1 Million in Digital Treasury Assets

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Oct 1, 2025, 8:30 AM EDT - 6 months ago

Profusa Adds a Leading French Critical Limb Ischemia Surgeon to Customer Base

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Sep 11, 2025, 8:30 AM EDT - 6 months ago

Profusa Adopts NVIDIA-Powered Technology to Build AI-Driven Insight Portal for Continuous Biomarker Monitoring

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Sep 4, 2025, 8:30 AM EDT - 6 months ago

Profusa Adds Head of Vascular Surgery Department at AZ Sint Blasius Hospital, Belgium to Growing Customer Base

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Aug 27, 2025, 8:45 AM EDT - 7 months ago

Profusa Announces Commercial and Clinical Collaboration with Head of Angiography, Medical University of Graz, Austria

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Aug 19, 2025, 8:15 AM EDT - 7 months ago

Profusa Welcomes Former Acting U.S. Veterans Affairs Secretary Peter O'Rourke as Lead Independent Director; Adds Seasoned Finance Executive Fred Knechtel as CFO

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Aug 6, 2025, 8:15 AM EDT - 8 months ago

Profusa, Inc. Provides Strategy Overview and Business Update for Investors

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Jul 31, 2025, 8:15 AM EDT - 8 months ago

Profusa Secures Lumee™ Oxygen Platform Distributor in Spain

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Jul 21, 2025, 8:00 AM EDT - 8 months ago

Profusa Announces $100 Million Equity Line of Credit to Initiate Bitcoin Treasury Strategy

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Jul 11, 2025, 4:00 PM EDT - 8 months ago

Profusa Announces Closing of Business Combination and the Commencement of Trading on Nasdaq

Eric1072
Eric1072 Mar. 19 at 5:25 AM
$PFSA Someone bought 16,325 shares at the close yesterday at 16 pm.
1 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 19 at 2:57 AM
$PFSA Ben Hwang is one corrupt SOB. HE WILL ROB YOU BLIND.
0 · Reply
Old_Bag
Old_Bag Mar. 19 at 1:04 AM
$PFSA worthless trash
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 19 at 12:47 AM
$PFSA You have no idea how the markets work. Are you even in age to trade? You Clown.
0 · Reply
alby777
alby777 Mar. 19 at 12:10 AM
$PFSA M&A? Glad to see Insiders owning a ton of PFSA shares!
0 · Reply
alby777
alby777 Mar. 18 at 11:37 PM
$PFSA Yes, insiders hold a significant portion of Profusa, Inc. (PFSA) shares. Key details regarding insider ownership (based on data available as of early 2026) include: Ownership Percentage: Insiders hold approximately 7.8% to 11% of Profusa's outstanding common stock. Individual Holdings: Key insiders hold large positions. For example, reports show individuals like Fred S. Knechtel and Jack E. Stover holding millions of shares. Insider Trading: Recent data suggests high insider activity, with reports of over 8 million shares bought in recent transactions. Significant Owners: Insiders, defined as executives, directors, and beneficial holders of more than 10%, play a major role in the company's equity ownership I'll buy more shares in this price range :)
1 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:52 PM
$PFSA this reminds me of nkgn They have great ideas, science but some how i tnink greed ends it
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:50 PM
$PFSA there is better next time
0 · Reply
NolAsrtormZ
NolAsrtormZ Mar. 18 at 8:50 PM
$PFSA does Whang have oxygen is head? Perhaps
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 6:50 PM
$PFSA
0 · Reply
Eric1072
Eric1072 Mar. 18 at 6:50 PM
$PFSA
0 · Reply
jeni1988
jeni1988 Mar. 18 at 6:49 PM
$PFSA 🤡🤡🤡🤡🤮🤮🤮🤮🤮
0 · Reply
Hydrojim
Hydrojim Mar. 18 at 6:29 PM
$PFSA
0 · Reply
WillyBagman
WillyBagman Mar. 18 at 5:11 PM
$PFSA imagine deciding to buy BTC at the all time high and tanking your company because of that decision. Shame on Ben
1 · Reply
Eric1072
Eric1072 Mar. 18 at 4:52 PM
$PFSA https://au.investing.com/news/sec-filings/profusa-to-liquidate-bitcoin-holdings-and-faces-nasdaq-delisting-process-93CH-4309911
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 4:45 PM
$PFSA Monday morning delisting lol! 😂 People don’t realize how low this will go. CEO spent millions and millions on R &D CEO spent millions on Bitcoin. CEO burnt institution investors, PFSA will pay dearly for the actions. Read my posts, I told you this would happen. I wrote CEO and he told me to f off. This is the turnout.
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 4:01 PM
$PFSA It’s going Pink the CEO Ben Hwang is a crook. He steals from his shareholders. He’s a thief.
0 · Reply
majsterJoda
majsterJoda Mar. 18 at 3:57 PM
$PFSA looks like delist leaked today
2 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 3:53 PM
$PFSA You can say good bye to your money, don’t get Mad at me, you can thank all the pumpers here. I warned you all day after day. That’s my job.
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 3:45 PM
$PFSA Ben Hwang screwed his shareholders real real good. lol! What a POS.
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 3:41 PM
$PFSA This little piggy is going pink. CEO is a crook.
0 · Reply
Bunch_of_Balonney
Bunch_of_Balonney Mar. 18 at 2:48 PM
$PFSA Y’all see now why Hwang is a POS now?
0 · Reply